Curtis R. Sprouse, President
Curtis R. Sprouse brings more than eighteen years of experience in the healthcare, pharmaceutical and accounting industries to his position as President at Boston Market Strategies, Inc. (BMSI), the Massachusetts-based management consulting firm that provides clinical trial support, strategic planning, and market development and research to life sciences companies and their industry partners. As a noted strategist and one of BMSI's founding members, Curt has worked with almost every major United States-based healthcare, pharmaceutical and biotechnology company, including Aetna, Astellas, AstraZeneca, BioAdvance, Boehringer Ingelheim, Cephalon, Cigna, Fujisawa, Genentech, GlaxoSmithKline, Harvard School of Public Health, Novartis, Oxford Health Plans, Pharma US, Sanofi and Pfizer.
As an independent consultant to these Fortune 500 companies, Curt has advised on sales, marketing, strategic planning and reimbursement issues. He structured and negotiated contractual relationships between pharmaceutical companies and managed care organizations and established BMSI as an expert resource in creating efficiencies in clinical trials processes. Curt created business and marketing strategies to support the successful launch of numerous pharmaceutical products, including Adenoscan®, Ambisome®, Pulmicort®, Toprol XL® and Tilade®.
Prior to founding BMSI, Curt was successful as Director of Special Projects for a New England-based healthcare business development organization. He also served as Chief Financial Officer for two start-up staffing ventures that placed medical professionals in temporary positions at New England hospitals, clinics and convalescent homes. Curt started as staff auditor at Big Eight accounting firm, Ernst & Young (then Whinney), where he excelled at healthcare-related accounting for several prestigious Pittsburgh-area hospitals and health-related ventures.
He holds a Bachelor of Arts degree in Accounting from Westminster College in Wilmington, Pennsylvania.